The European Medicines Agency says it will convene a meeting on Dec. 29 to decide if there is enough data about the safety and efficacy of the COVID-19 vaccine developed by Pfizer and BioNTech for it to be approved
Related posts
-
Top 2023-24 moments in boys prep sports
It’s time to present the top boys prep sports moments of the 2023-24 school year. -
Chicago police discipline again on hold as public arbitration hearings near
For the second time this year, the majority of serious Chicago police misconduct cases are on... -
Can Cubs’ upswing in pitching development continue without key executive?
The #Cubs lost the executive credited with improving their pitching development during the off-season. Will the...